1. Главная
  2. Ресурсы
  3. Библиотечный поиск
GLP-1-(9–36) amidereduces blood glucosein anesthetized pigsby a mechanism thatdoes not involveinsulin secretion Carolyn F. DeaconAstrid PlamboeckSøren Møller2002 год

GLP-1-(9–36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion
статья из журнала

Страница публикацииПубликация в OpenAlex
Аннотация: Glucagon-like peptide 1 (GLP-1) is a potent anti-hyperglycemic hormone currently under investigation for its therapeutic potential. However, due to rapid degradation by dipeptidyl peptidase IV (DPP IV), which limits its metabolic stability and eliminates its insulinotropic activity, it has been impossible to assess its true efficacy in vivo. In chloralose-anesthetized pigs given valine-pyrrolidide (to block endogenous DPP IV activity), the independent effects of GLP-1-(7–36) amide on glucose and insulin responses to intravenous glucose were assessed, and the metabolite generated by DPP IV, GLP-1-(9–36) amide, was investigated for any ability to influence these responses. GLP-1-(7–36) amide enhanced insulin secretion ( P < 0.03 vs. vehicle), but GLP-1-(9–36) amide was without effect, either alone or when coinfused with GLP-1-(7–36) amide. In contrast, GLP-1-(9–36) amide did affect glucose responses ( P < 0.03). Glucose excursions were greater after saline (121 ± 17 mmol · l −1 · min) than after GLP-1-(9–36) amide (73 ± 19 mmol · l −1 · min; P < 0.05), GLP-1-(7–36) amide (62 ± 13 mmol · l −1 · min; P < 0.02) or GLP-1-(7–36) amide + GLP-1-(9–36) amide (50 ± 13 mmol · l −1 · min; P < 0.005). Glucose elimination rates were faster after GLP-1-(7–36) amide + (9–36) amide (10.3 ± 1.2%/min) than after GLP-1-(7–36) amide (7.0 ± 0.9%/min; P < 0.04), GLP-1-(9–36) amide (6.8 ± 1.0%/min; P < 0.03), or saline (5.4 ± 1.2%/min; P < 0.005). Glucagon concentrations were unaffected. These results demonstrate that GLP-1-(9–36) amide neither stimulates insulin secretion nor antagonizes the insulinotropic effect of GLP-1-(7–36) amide in vivo. Moreover, the metabolite itself possesses anti-hyperglycemic effects, supporting the hypothesis that selective DPP IV action is important in glucose homeostasis.
Год издания: 2002
Авторы: Carolyn F. Deacon, Astrid Plamboeck, Søren Møller, Jens J. Holst
Издательство: American Physiological Society
Источник: AJP Endocrinology and Metabolism
Ключевые слова: Diabetes Treatment and Management, Neuropeptides and Animal Physiology, Pancreatic function and diabetes
Другие ссылки: AJP Endocrinology and Metabolism (HTML)
PubMed (HTML)